CPhI Worldwide announces the winners of the 16th Pharma Awards

CPhI Worldwide 2019 5 - 7 November 2019, Frankfurt, Germany.
CPhI Worldwide, organised by Informa PLC, announced the winners of the prestigious 2019 CPhI Pharma Awards - celebrating the industry's top innovators, performers and outstanding achievements across 13 categories, spanning the entire industry supply chain. The winners have been recognised for delivering excellence in pharma and were unveiled during a ceremony on the opening evening of CPhI Worldwide in Frankfurt.

The prestigious 'CEO of the Year' award has been bestowed upon Dr. Ge Li, Founder, Chairman and CEO of WuXi AppTec who was chosen for his significant contribution to the global biopharma R&D industry. Under his leadership, WuXi AppTec has become a highly respected contributor to global healthcare innovation. The company is enabling more than 3,700 customers and partners in more than 30 countries by offering open-access capabilities and services, accelerating the discovery and development of new medicines for patients around the world.

For the second time in three years, Cambrex was awarded the ‘API Development’ category for their Crystallisation Screening and Process Development Service. The service has bridged the gap between the bench and manufacturing plat, providing controlled, robust and scalable crystallization processes. Hovione received a ‘highly commended’ acknowledgement for their Process Ranking of Inputs from Manufacturing (PRIME).

John Chiminski, Chair and CEO at Catalent Pharma Solutions, won the ‘Lifetime Achievement’ award for his accomplishments spanning more than three decades. These include the last 10 years at Catalent, during which time the company has become a true benchmark of advanced delivery technologies, development, and manufacturing solutions.

The 'Formulation' award was given to Nanoform for its controlled expansion of supercritical solutions (CESS®). Spraying Systems Co. / Fluid Air Inc. were bestowed with the 'Manufacturing Technology and Equipment' award for their PolarDry®' - the Cooler Technology. Cited as the future of spray drying, it utilises electrostatic technology to prevent against API loss, degradation, and denaturalisation.

Univercells received the ‘Bioprocessing and Manufacturing’ award in recognition of its NevoLine PlatformTM, which is a bioproduction system for vaccines. The ‘Regulatory Procedures and Compliance' prize was given to Merck Healthcare KGaA for ‘Project SARA’ (Smart Assistant for Regulatory Affairs).

The 'Analysis, Testing, and Quality Control' category was claimed by MedPharm for pioneering the regulatory approval of topical products using in vitro bioequivalence. MedPharm is the first contract research organisation to gain regulatory approval using in vitro models to demonstrate the bioequivalence of a generic formulation compared to the originator.

SCHOTT Pharmaceutical Systems and W.L. Gore & Associates received the ‘Packaging’ award for its syriQ BioPure® - a silicone-free syringe - whilst Hoffmann Neopac was highly commended for their STYLO Spatula applicator.

The winner of the ‘Pharma Service Company of the Year Award’ is Lonza Pharma & Biotech. The company is recognised for its integrated global services offering that spans the pharmaceutical, biotech, consumer health and specialty chemicals market.

In 'Contract Services and Outsourcing' Nanopharm Ltd - an Aptar pharma company - was selected as the winner for SmartTrack™, with CMAC being highly commended for their CMAC National Facility. Finally, the award for 'Drug Delivery and Devices' was given to Phillips-Medisize for its Connected Health Platform, and the 'Supply Chain, Logistics and Distribution' category was given to Kemiex AG.

Tara Dougal, Head of Content at Informa, commented: "The judges noted that this year our entries possessed an extremely high standard. All of the finalists would have would have made outstanding winners in previous years. On behalf of CPhI Worldwide, I would like to extend my congratulations to all the winners and commend all of the finalists. What you are doing is of tremendous benefit to the industry, but more importantly, it is also directly contributing to improved patient experiences globally."

For more information on the CPhI Pharma Awards please visit: http://awards.cphi.com

The 2019 CPhI Pharma Award winner by category

  • Excellence in Pharma: Analysis, Testing, and Quality Control - MedPharm regulatory approval of topical products using in vitro bioequivalence
  • Excellence in Pharma: API Development - Cambrex crystallisation screening and process development service. Highly commended - Hovione process ranking of inputs from manufacturing
  • Excellence in Pharma: Bioprocessing & Manufacturing - Univercells The NevoLine PlatformTM
  • Excellence in Pharma: Contact Services and Outsourcing - Nanopharm Ltd, an Aptar Pharma Company Smart Track. Highly commended - CMAC, CMAC National Facility
  • Excellence in Pharma: Formulation - Nanoform Controlled Expansion of Supercritical Solutions
  • Excellence in Pharma: Manufacturing Technology and Equipment - Spraying Systems Co./Fluid Air Inc PolarDry The Cooler Technology
  • Excellence in Pharma: Drug Delivery Devices - Phillips-Medisize Connected Health Platform
  • Excellence in Pharma: Packaging - SCHOTT Pharmaceutical Systems and W.L Gore & Associates syriQ BioPure silicone-free syringes with GORE ImproJect Plungers. Highly commended - Hoffman Neopac STYLO Spatula applicator for Canseten footcare Cream Bayer Consumer Health
  • Excellence in Pharma: Regulatory Procedures and Compliance - Merck Healthcare KGaA Project SARA (Smart Assistant for Regulatory Affairs)
  • Excellence in Pharma: Supply Chain Logistics and Distribution - Kemlex AG Trade Network for Life Sciences Raw Materials
  • CEO of the Year: Dr. Ge Li, Founder, Chairman & CEO, WuXi AppTec
  • Pharma Service Company of the Year: Lonza Pharma & Biotech
  • Lifetime Achievement Award: John Chiminski, Chair and CEO at Catalent Pharma Solutions

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, North America, and the Middle East and Africa. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; bioLIVE for biopharma; and Finished Dosage Formulation for every aspect of the finished dosage supply chain.

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.

The Informa Markets annual schedule of Pharmaceutical events include: CPhI, ICSE, P-MEC, FDF, InnoPack Worldwide, BioProduction (5-7, November, 2019 at the Messe in Frankfurt); CPhI & P-MEC India (26 - 28 November 2019 at the India Expo Mart, Greater Noida, Delhi NCR - Delhi, India); Pharmapack Europe (5 - 6 February, 2020 at the Paris Expo, Porte de Versailles - Paris, France); CPhI South East Asia (4 - 6 March, 2020 at the QSNCC - Bangkok, Thailand); CPhI Japan (16 - 18 March, 2020 at the Big Sight Exhibition Centre - Tokyo, Japan); CPhI North America (05 April - 07 May, 2020 at Pennsylvania Convention Centre - Philadelphia, USA); CPhI and P-MEC China (22 - 24 June, 2020 at SNIEC - Shanghai, China); CPhI Korea (26 - 28 August 2020), COEX - Seoul, Korea); CPhI Middle East & Africa (14 - 16 September, 2020 at the ADNEC - Abu Dhabi, United Arab Emirates)

Most Popular Now

A step closer to cancer precision medicine

Researchers from the Faculty of Medicine and the Institute for Molecular Medicine (FIMM) at the University of Helsinki have developed a computational model, Combined Esse...

Artificial Intelligence algorithm can learn the la…

Artificial Intelligence can be used to predict molecular wave functions and the electronic properties of molecules. This innovative AI method developed by a team of resea...

Amgen completes acquisition of Otezla® (apremilast…

Amgen (NASDAQ:AMGN) today announced the successful completion of its acquisition of worldwide rights to Otezla® (apremilast), the only oral, non-biologic treatment for mo...

Bristol-Myers Squibb completes acquisition of Celg…

Bristol-Myers Squibb Company (NYSE:BMY) has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all governmen...

Amgen and the Duke Clinical Research Institute ann…

Amgen (NASDAQ:AMGN) in collaboration with the Duke Clinical Research Institute (DCRI) announced plans to initiate the Cardiovascular Multi-dimensional Observational Inves...

Statins not associated with memory or cognition de…

Given consumer concern that statins may be associated with memory or cognitive decline, a new study published today in the Journal of the American College of Cardiology m...

Novartis announces new strategy to provide innovat…

Novartis announced a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa (SSA), which is home to the largest unders...

New advances in the treatment of advanced lung can…

The University of Barcelona (UB) and Hospital Clínic de Barcelona collaborate with Boehringer Ingelheim Inc. to improve the efficiency of nintedanib, an antiangiogenic an...

FDA grants priority review to Roche’s risdiplam fo…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review for ...

A protein tag to study the immune system

Researchers from VIB-UGent Center for Medical Biotechnology, University of Iowa (USA) and other collaborators, developed a novel approach to better understand a basic def...

Bayer and Dewpoint Therapeutics partner to researc…

Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, today announced an option, research and license agreement worth up to ...

Pharmacist-led interventions may help prevent card…

With their expertise in the safe and effective use of medications, pharmacists can help in the management of chronic diseases. A review and analysis published in the Brit...